330 related articles for article (PubMed ID: 33245404)
1. Drug Repurposing in Medulloblastoma: Challenges and Recommendations.
Hammoud H; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
Curr Treat Options Oncol; 2020 Nov; 22(1):6. PubMed ID: 33245404
[TBL] [Abstract][Full Text] [Related]
2. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Genovesi LA; Millar A; Tolson E; Singleton M; Hassall E; Kojic M; Brighi C; Girard E; Andradas C; Kuchibhotla M; Bhuva DD; Endersby R; Gottardo NG; Bernard A; Adolphe C; Olson JM; Taylor MD; Davis MJ; Wainwright BJ
Genome Med; 2021 Jun; 13(1):103. PubMed ID: 34154646
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targets for medulloblastoma.
Wlodarski PK; Jozwiak J
Expert Opin Ther Targets; 2008 Apr; 12(4):449-61. PubMed ID: 18348681
[TBL] [Abstract][Full Text] [Related]
4. The biologic era of childhood medulloblastoma and clues to novel therapies.
Khatua S; Zaky W
Future Oncol; 2014 Mar; 10(4):637-45. PubMed ID: 24754593
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma in two successive pregnancies.
Razak AR; Nasser Q; Morris P; Alcutt D; Grogan L
J Neurooncol; 2005 May; 73(1):89-90. PubMed ID: 15933823
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Cerebellar Desmoplastic/Nodular Medulloblastoma in Cerebrospinal Fluid (CSF) in the Elderly. A Cytologic Diagnosis.
Kalogeraki A; Tamiolakis D; Mavrigiannaki P; Karvelaskalogerakis M; Datseri G; Agelaki S; Papadopoulos S
Rom J Intern Med; 2016; 54(2):137-9. PubMed ID: 27352444
[TBL] [Abstract][Full Text] [Related]
8. c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.
von Bueren AO; Oehler C; Shalaby T; von Hoff K; Pruschy M; Seifert B; Gerber NU; Warmuth-Metz M; Stearns D; Eberhart CG; Kortmann RD; Rutkowski S; Grotzer MA
BMC Cancer; 2011 Feb; 11():74. PubMed ID: 21324178
[TBL] [Abstract][Full Text] [Related]
9. Childhood medulloblastoma: current status of biology and treatment.
Klesse LJ; Bowers DC
CNS Drugs; 2010 Apr; 24(4):285-301. PubMed ID: 20297854
[TBL] [Abstract][Full Text] [Related]
10. Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy.
Schiavetti A; Varrasso G; Maurizi P; Trasimeni G; Carapella C; Castello MA
J Neurooncol; 1999; 45(1):55-60. PubMed ID: 10728910
[TBL] [Abstract][Full Text] [Related]
11. Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.
Mosijczuk AD; Nigro MA; Thomas PR; Burger PC; Krischer JP; Morantz RA; Kurdunowicz B; Mulne AF; Towbin RB; Freeman AI
Cancer; 1993 Nov; 72(9):2755-62. PubMed ID: 8402500
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
Packer RJ
Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
[TBL] [Abstract][Full Text] [Related]
13. Primary Burkitt lymphoma of the fourth ventricle mimicking a medulloblastoma in a child.
Liu H; Hou H; Cheng J
J Neurooncol; 2016 Mar; 127(1):205-7. PubMed ID: 26703786
[No Abstract] [Full Text] [Related]
14. Perspectives: Chemotherapy of medulloblastoma.
Mastrangelo S; Tornesello A; Mastrangelo R
Med Pediatr Oncol; 1999 Aug; 33(2):116-9. PubMed ID: 10398188
[No Abstract] [Full Text] [Related]
15. The therapy of infantile malignant brain tumors: current status?
Kalifa C; Grill J
J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
[TBL] [Abstract][Full Text] [Related]
16. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy.
Audi ZF; Saker Z; Rizk M; Harati H; Fares Y; Bahmad HF; Nabha SM
Curr Treat Options Oncol; 2021 Jul; 22(9):83. PubMed ID: 34328587
[TBL] [Abstract][Full Text] [Related]
18. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma drugs in development: Current leads, trials and drawbacks.
Wen J; Hadden MK
Eur J Med Chem; 2021 Apr; 215():113268. PubMed ID: 33636537
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma--challenges in radiation therapy and the addition of chemotherapy.
Kun LE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):261-3. PubMed ID: 10661329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
